Agaoglu, A.B.; Erdogan, A.P.; Ekinci, F.; Sahbazlar, M.; Tekustun, G.N.; Tanriverdi, O.; Tunbekici, S.; Goker, E.; Akarca, M.S.; Cangur, C.;
et al. Neoadjuvant Regimens and Their Impact on Adjuvant T-DM1 Outcomes in HER2-Positive Early Breast Cancer. Medicina 2025, 61, 1966.
https://doi.org/10.3390/medicina61111966
AMA Style
Agaoglu AB, Erdogan AP, Ekinci F, Sahbazlar M, Tekustun GN, Tanriverdi O, Tunbekici S, Goker E, Akarca MS, Cangur C,
et al. Neoadjuvant Regimens and Their Impact on Adjuvant T-DM1 Outcomes in HER2-Positive Early Breast Cancer. Medicina. 2025; 61(11):1966.
https://doi.org/10.3390/medicina61111966
Chicago/Turabian Style
Agaoglu, Ahmet Burak, Atike Pinar Erdogan, Ferhat Ekinci, Mustafa Sahbazlar, Guler Nur Tekustun, Ozgur Tanriverdi, Salih Tunbekici, Erdem Goker, Mehmet Sinan Akarca, Can Cangur,
and et al. 2025. "Neoadjuvant Regimens and Their Impact on Adjuvant T-DM1 Outcomes in HER2-Positive Early Breast Cancer" Medicina 61, no. 11: 1966.
https://doi.org/10.3390/medicina61111966
APA Style
Agaoglu, A. B., Erdogan, A. P., Ekinci, F., Sahbazlar, M., Tekustun, G. N., Tanriverdi, O., Tunbekici, S., Goker, E., Akarca, M. S., Cangur, C., Guclu Kantar, T., Biter, S., Bayram, E., Colak, G., Demir, B., Basir, H., & Ercolak, V.
(2025). Neoadjuvant Regimens and Their Impact on Adjuvant T-DM1 Outcomes in HER2-Positive Early Breast Cancer. Medicina, 61(11), 1966.
https://doi.org/10.3390/medicina61111966
